Objective To compare the efficacy of bone pâté versus bioactive glass in mastoid obliteration. Method This randomised parallel groups study was conducted at a tertiary care centre between September 2017 and August 2019. Sixty-eight patients, 33 males and 35 females, aged 12–56 years, randomly underwent single-stage canal wall down mastoidectomy with mastoid obliteration using either bone pâté (n = 35) or bioactive glass (n = 33), and were evaluated 12 months after the operation. Results A dry epithelised cavity (Merchant's grade 0 or 1) was achieved in 65 patients (95.59 per cent). Three patients (4.41 per cent) showed recidivism. The mean air–bone gap decreased to 16.80 ± 4.23 dB from 35.10 ± 5.21 dB pre-operatively. The mean Glasgow Benefit Inventory score was 30.02 ± 8.23. There was no significant difference between the two groups in these outcomes. However, the duration of surgery was shorter in the bioactive glass group (156.87 ± 7.83 vs 162.28 ± 8.74 minutes; p = 0.01). Conclusion The efficacy of both materials was comparable.
<p class="abstract"><strong>Background:</strong> Deviated nasal septum is one of the most common disorders in human beings, which may lead to symptoms of nasal obstruction, headache, epistaxis, hyposmia, and post nasal drip. DNS correction may also be required to gain access during intranasal procedures like endoscopic sinus surgery, endoscopic dacryocystor-hinostomy and skull base surgery. The technique of septoplasty has evolved over the decades with a tendency towards more conservative and precise surgery. Over the last few decades endoscopic septoplasty has become increasingly popular.</p><p class="abstract"><strong>Methods:</strong> It was a cross-sectional comparative study done to compare the efficacy of endoscopic septoplasty with conventional septoplasty, conducted at a tertiary care centre over a period of 3 years. Records of 100 patients of nose and PNS disorders with DNS who were operated either by conventional or by endoscopic technique were studied. The patients were studied for the improvement in their symptoms, anatomical correction and intra-operative/post-operative complications. </p><p class="abstract"><strong>Results:</strong> Endoscopic septoplasty group patients showed better symptomatic relief, lesser incidence of residual anterior /posterior deviation and persistent spur and less complications as compared to the conventional septoplasty group.</p><p><strong>Conclusions:</strong> In our study we found more clientele satisfaction and lesser rate of complications in endoscopic septoplasty group. We recommend all ENT specialists to be trained in nasal endoscopic septoplasty technique as it offers many advantages such as more precision in post nasal spurs with less flap tears, it can be tailor made according to the disease and can be combined with various endoscopic surgeries.</p>
Superficial parotidectomy is the biopsy procedure of choice for all parotid neoplasm's as well as therapeutic choice for small low-grade malignancies. The key to successful parotid surgery is identification of the facial nerve. It is usually done under general anesthesia (GA).The main focus in this procedure is to remove entire superficial parotid gland along with a disease and at the same time preventing any iatrogenic injury to facial nerve and its peripheral branches which supplies over the face. We present three cases of superficial parotidectomies done under local anesthesia technique. The objectives of these reports are to discuss the clinical presentation, diagnosis and management of these growths surgically under local as an alternative method or when it is desired under some special circumstances and the merits. This technique may avoid the use of facial nerve monitor.
<p class="abstract"><strong>Background:</strong> Allergic rhinitis (AR) is a chronic disease with variable response to therapy.<strong> </strong>Nasal irrigation with saline, including hypertonic saline, has been recommended for sinonasal conditions<span lang="EN-IN">. </span></p><p class="abstract"><strong>Methods:</strong> All consecutive patients reporting with AR symptoms established by ARIA at a zonal and tertiary care referral hospital from July 1 to September 30, 2015 were enrolled in the study. Patients were randomly divided into two groups. Patients in Group A were treated with hypertonic seawater saline (HSS) 2.2% Group B with normal saline (NS) 0.9% respectively. Symptoms were assessed at the start of the treatment and after 2 months using 4 point scale.<strong></strong>60 patients were included in final analysis<span lang="EN-IN">. </span></p><p class="abstract"><strong>Results:</strong> The mean total nasal symptoms post treatment when compared to pre-treatment were low in both the groups [2.19 (pre- treatment) vs. 1.03 (post treatment) in Group A and 2.18 (pre-treatment) vs. 1.46 (post treatment) in Group B] and the difference was statistically significant for both groups (P =0.0001). On comparing post-treatment symptom scores between both groups, Group a benefitted more than Group B and it was statistically significant (P =0.002). The difference in individual symptom improvement (except sneezing) post treatment exhibited a statistical significance in Group A.No side-effects were seen with either of the sprays<span lang="EN-IN">. </span></p><p class="abstract"><strong>Conclusions:</strong> In our study, both treatments provided clinically meaningful responses, but the overall result favored HSS. Hence, HSS can be an effective and safe therapy for AR<span lang="EN-IN">.</span></p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.